Dongwha Pharm has solidified its system under Chief Executive Officer and President Yun In-ho (41), the fourth generation of the founding family. Yun is the eldest son of Chairman Yun Do-jun (73) of Dongwha Pharm.
According to the industry on the 8th, Vice Chairman Yun Gil-jun (68), the younger brother of Chairman Yun Do-jun who led the company together with Yun, retired at the end of last month.
Former Dongwha Pharm Vice Chairman Yun Gil-jun joined Dongwha Pharm in 1985, became CEO and president in 2003, and was promoted to vice chairman in 2008.
Yun's older sister, Executive Director Yun Hyun-kyung (46), also stepped back from the front line of management starting last month, taking on an advisory role related to the field of corporate social responsibility (CSR) that she had overseen.
After joining the finance department of Dongwha Pharm in Aug. 2013, Yun was promoted to CEO and president in March last year. The company is currently run under a co-CEO structure with professional manager Yu Jun-ha, with Yu Jun-ha and Yun In-ho each serving as representative directors. After that, in Nov. last year, the company reorganized by replacing key executives. A number of executives in their 50s are known to have left the company.
A Dongwha Pharm official said, "Vice Chairman Yun Gil-jun reached the mandatory retirement age and retired as of 2025," adding, "Advisor Yun Hyun-kyung plans to focus on her advisory role in the CSR field."